{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:27:42Z","timestamp":1787070462841,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Biomedical institute of Chonnam National University Hospital","award":["BCR120006"],"award-info":[{"award-number":["BCR120006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kawasaki disease (KD) is an acute, self-limited febrile illness of unknown cause. Intravenous immunoglobulin (IVIG)-resistance are related to greater risk for permanent cardiac complications. We aimed to determine the correlation between monocytes and the phenotype of KD in relation to IVIG responsiveness in children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p> The study cohort included 62 patients who were diagnosed with KD, 20 non febrile healthy controls (NFC), and 15 other febrile controls (OFC). In all enrolled patients, blood was taken at least 4 times and laboratory tests were performed. In addition, subtypes of monocytes were characterized via flow cytometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The numbers of intermediate monocytes were significantly lower in IVIG-resistant group compared to IVIG-responsive group before IVIG infusion (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). After infusion, intermediate monocytes decreased in the responsive group, while a trend of increase was observed in the resistant group. Only intermediate monocytes were significant in logistic regression with adjusted OR of 0.001 and <jats:italic>p<\/jats:italic> value of 0.03.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>CD14\u2009+\u2009CD16\u2009+\u2009intermediate monocyte may play an important role in IVIG responsiveness among KD children. Low starting levels of intermediate monocytes, followed by a dramatic increase post-IVIG infusion during acute phase of KD are associated with IVIG-resistance. Functional studies on intermediate monocyte may help to reveal the pathophysiology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-021-00573-7","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T08:04:21Z","timestamp":1622448261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The \u201cIntermediate\u201d CD14\u2009+\u2009CD16\u2009+\u2009monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Yi Seul","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jung","family":"Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisoo","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina K","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Seok","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-8529","authenticated-orcid":false,"given":"Hwa Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"issue":"3","key":"573_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1542\/peds.54.3.271","volume":"54","author":"T Kawasaki","year":"1974","unstructured":"Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54(3):271\u20136.","journal-title":"Pediatrics"},{"issue":"1","key":"573_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","volume":"153","author":"AH Tremoulet","year":"2008","unstructured":"Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153(1):117\u201321.","journal-title":"J Pediatr"},{"key":"573_CR3","doi-asserted-by":"crossref","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927-e99.","DOI":"10.1161\/CIR.0000000000000484"},{"issue":"5","key":"573_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/BOR.0b013e32833cf051","volume":"22","author":"RS Yeung","year":"2010","unstructured":"Yeung RS. Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol. 2010;22(5):551\u201360.","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 1","key":"573_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2249.2011.04361.x","volume":"164","author":"K Takahashi","year":"2011","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y. Pathogenesis of Kawasaki disease. Clin Exp Immunol. 2011;164(Suppl 1):20\u20132.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"573_CR6","first-page":"333","volume":"44","author":"GB Wang","year":"2006","unstructured":"Wang GB, Li CR, Zu Y, Yuan XW. [The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki disease]. Zhonghua Er Ke Za Zhi. 2006;44(5):333\u20136.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"7","key":"573_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1440-1827.1998.tb03942.x","volume":"48","author":"M Koga","year":"1998","unstructured":"Koga M, Ishihara T, Takahashi M, Umezawa Y, Furukawa S. Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation. Pathol Int. 1998;48(7):512\u20137.","journal-title":"Pathol Int"},{"issue":"3","key":"573_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1046\/j.1365-2249.2000.01321.x","volume":"121","author":"K Katayama","year":"2000","unstructured":"Katayama K, Matsubara T, Fujiwara M, Koga M, Furukawa S. CD14 + CD16 + monocyte subpopulation in Kawasaki disease. Clin Exp Immunol. 2000;121(3):566\u201370.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"573_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0090-1229(88)90088-8","volume":"48","author":"S Furukawa","year":"1988","unstructured":"Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte\/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol. 1988;48(2):247\u201351.","journal-title":"Clin Immunol Immunopathol"},{"issue":"5940","key":"573_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (New York, NY). 2009;325(5940):pp.\u00a0612\u20136.","journal-title":"Science (New York, NY)."},{"issue":"11","key":"573_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11(11):762\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"573_CR12","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74\u201380.","journal-title":"Blood"},{"issue":"4","key":"573_CR13","doi-asserted-by":"publisher","first-page":"e0176460","DOI":"10.1371\/journal.pone.0176460","volume":"12","author":"LB Boyette","year":"2017","unstructured":"Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PloS one. 2017;12(4):e0176460.","journal-title":"PloS one"},{"issue":"5","key":"573_CR14","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"KL Wong","year":"2011","unstructured":"Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood. 2011;118(5):e16\u201331.","journal-title":"Blood"},{"issue":"1\u20133","key":"573_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","volume":"53","author":"KL Wong","year":"2012","unstructured":"Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM, Wong SC. The three human monocyte subsets: implications for health and disease. Immunol Res. 2012;53(1\u20133):41\u201357.","journal-title":"Immunol Res"},{"issue":"5","key":"573_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ibd.20025","volume":"13","author":"O Grip","year":"2007","unstructured":"Grip O, Bredberg A, Lindgren S, Henriksson G. Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn\u2019s disease. Inflamm Bowel Dis. 2007;13(5):566\u201372.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"573_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","volume":"32","author":"KS Rogacev","year":"2011","unstructured":"Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, et al. CD14 + + CD16 + monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J. 2011;32(1):84\u201392.","journal-title":"Eur Heart J"},{"issue":"3","key":"573_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/art.33418","volume":"64","author":"M Rossol","year":"2012","unstructured":"Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U. The CD14(bright) CD16 + monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 2012;64(3):671\u20137.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"573_CR19","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1097\/MIB.0000000000000824","volume":"22","author":"ST Gren","year":"2016","unstructured":"Gren ST, Grip O. Role of Monocytes and Intestinal Macrophages in Crohn\u2019s Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2016;22(8):1992\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"573_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0046-8177(90)90135-R","volume":"21","author":"M Terai","year":"1990","unstructured":"Terai M, Kohno Y, Namba M, Umemiya T, Niwa K, Nakajima H, et al. Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol. 1990;21(2):231\u20134.","journal-title":"Hum Pathol"},{"key":"573_CR21","first-page":"185","volume":"250","author":"T Sugawara","year":"1987","unstructured":"Sugawara T, Hattori S, Hirose S, Furukawa S, Yabuta K, Shirai T. Immunopathology of the skin lesion of Kawasaki disease. Prog Clin Biol Res. 1987;250:185\u201392.","journal-title":"Prog Clin Biol Res"},{"issue":"6","key":"573_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/adc.67.6.706","volume":"67","author":"S Furukawa","year":"1992","unstructured":"Furukawa S, Matsubara T, Yabuta K. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child. 1992;67(6):706\u20138.","journal-title":"Arch Dis Child"},{"issue":"1","key":"573_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/BF02073890","volume":"151","author":"S Furukawa","year":"1992","unstructured":"Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr. 1992;151(1):44\u20137.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"573_CR24","first-page":"651","volume":"113","author":"CP Maury","year":"1989","unstructured":"Maury CP, Salo E, Pelkonen P. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med. 1989;113(5):651\u20134.","journal-title":"J Lab Clin Med"},{"issue":"8675","key":"573_CR25","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/S0140-6736(89)91910-7","volume":"2","author":"DY Leung","year":"1989","unstructured":"Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. 1989;2(8675):1298\u2013302.","journal-title":"Lancet"},{"issue":"11","key":"573_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/intimm\/dxx039","volume":"29","author":"C Galeotti","year":"2017","unstructured":"Galeotti C, Kaveri SV, Bayry J. IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol. 2017;29(11):491\u20138.","journal-title":"Int Immunol"},{"issue":"3","key":"573_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/art.38910","volume":"67","author":"JF S\u00e9\u00eft\u00e9","year":"2015","unstructured":"S\u00e9\u00eft\u00e9 JF, Hillion S, Harbonnier T, Pers JO. Review: intravenous immunoglobulin and B cells: when the product regulates the producer. Arthritis Rheumatol (Hoboken, NJ). 2015;67(3):595\u2013603.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)."},{"issue":"1","key":"573_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41419-020-2249-y","volume":"11","author":"M Das","year":"2020","unstructured":"Das M, Karnam A, Stephen-Victor E, Gilardin L, Bhatt B, Kumar Sharma V, et al. Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy. Cell Death Dis. 2020;11(1):50.","journal-title":"Cell Death Dis"},{"key":"573_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fimmu.2013.00088","volume":"4","author":"A Bhattacharya","year":"2013","unstructured":"Bhattacharya A, Eissa NT. Autophagy and autoimmunity crosstalks. Front Immunol. 2013;4:88.","journal-title":"Front Immunol"},{"issue":"1","key":"573_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.20061303","volume":"204","author":"HH Pua","year":"2007","unstructured":"Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med. 2007;204(1):25\u201331.","journal-title":"J Exp Med"},{"issue":"9","key":"573_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrrheum.2016.92","volume":"12","author":"JS Rockel","year":"2016","unstructured":"Rockel JS, Kapoor M. Autophagy: controlling cell fate in rheumatic diseases. Nat Rev Rheumatol. 2016;12(9):517\u201331.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"573_CR32","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ng2032","volume":"39","author":"JD Rioux","year":"2007","unstructured":"Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39(5):596\u2013604.","journal-title":"Nat Genet"},{"issue":"5","key":"573_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/annrheumdis-2012-201671","volume":"72","author":"NY Lin","year":"2013","unstructured":"Lin NY, Beyer C, Giessl A, Kireva T, Scholtysek C, Uderhardt S, et al. Autophagy regulates TNF\u03b1-mediated joint destruction in experimental arthritis. Ann Rheum Dis. 2013;72(5):761\u20138.","journal-title":"Ann Rheum Dis"},{"key":"573_CR34","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3389\/fimmu.2018.01512","volume":"9","author":"H Yin","year":"2018","unstructured":"Yin H, Wu H, Chen Y, Zhang J, Zheng M, Chen G, et al. The Therapeutic and Pathogenic Role of Autophagy in Autoimmune Diseases. Front Immunol. 2018;9:1512.","journal-title":"Front Immunol"},{"key":"573_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaut.2018.08.009","volume":"94","author":"SR Bonam","year":"2018","unstructured":"Bonam SR, Wang F, Muller S. Autophagy. A new concept in autoimmunity regulation and a novel therapeutic option. J Autoimmun. 2018;94:16\u201332.","journal-title":"J Autoimmun"},{"issue":"9","key":"573_CR36","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.4049\/jimmunol.174.9.5837","volume":"174","author":"J Abe","year":"2005","unstructured":"Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol. 2005;174(9):5837\u201345.","journal-title":"J Immunol"},{"issue":"22","key":"573_CR37","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606\u201312.","journal-title":"Circulation"},{"issue":"2","key":"573_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237\u201340.","journal-title":"J Pediatr"},{"issue":"2","key":"573_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007;166(2):131\u20137.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"573_CR40","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","volume":"17","author":"JC Burns","year":"1998","unstructured":"Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J. 1998;17(12):1144\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"573_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2008-0730","volume":"124","author":"MB Son","year":"2009","unstructured":"Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009;124(1):1\u20138.","journal-title":"Pediatrics"},{"issue":"5","key":"573_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","volume":"158","author":"LA Sleeper","year":"2011","unstructured":"Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831\u20135.e3.","journal-title":"J Pediatr"},{"issue":"1","key":"573_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF01959479","volume":"150","author":"S Furukawa","year":"1990","unstructured":"Furukawa S, Matsubara T, Jujoh K, Sasai K, Nakachi S, Sugawara T, et al. Reduction of peripheral blood macrophages\/monocytes in Kawasaki disease by intravenous gammaglobulin. Eur J Pediatr. 1990;150(1):43\u20137.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"573_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1006\/clim.2001.5026","volume":"99","author":"T Ichiyama","year":"2001","unstructured":"Ichiyama T, Yoshitomi T, Nishikawa M, Fujiwara M, Matsubara T, Hayashi T, et al. NF-kappaB activation in peripheral blood monocytes\/macrophages and T cells during acute Kawasaki disease. Clin Immunol (Orlando Fla). 2001;99(3):373\u20137.","journal-title":"Clin Immunol (Orlando Fla)"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00573-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-021-00573-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00573-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T03:06:12Z","timestamp":1675393572000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00573-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00573-7","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"19 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional Review Board (CNUH-2017-257) and was conducted in accordance with Good Clinical Practice guideline and ethical standards as laid down in the 1964 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}